期刊文献+

维持性血液透析患者心脏结构与功能改变及左心室舒张功能减退的相关影响因素分析 被引量:7

Cardiac Structural and Functional Changes of Maintenance Hemodialysis Patients and Associated Risk Factors: A Cross Sectional Study
下载PDF
导出
摘要 目的检测维持性血液透析(MHD)患者的心脏结构和功能改变,并探讨左心室舒张功能减退的相关影响因素。方法回顾性纳入2012年广东省中医院透析科收治的血液透析1年以上且病情稳定的患者100例,均在行透析治疗前应用多普勒超声检测心脏结构与功能各项指标,收集患者的相关临床信息及同期实验室检查结果。采用多元逐步回归模型分析影响左心室舒张功能减退的相关因素。结果 100例MHD患者中左心室心肌肥厚和左心室舒张功能减退发生率分别为82%和69%。根据舒张早期和晚期最大血流速度比(E/A)分为舒张功能减退组(E/A<1,n=69)与舒张功能正常组(E/A≥1,n=31),两组患者的年龄、超滤量、超滤量/体质量、体质指数、右心室内径、左心室舒张末期内径间差异有统计学意义(P<0.05);多元逐步回归分析显示,右心室内径和超滤量/体质量是左心室舒张功能的影响因素。结论 MHD患者左心室心肌肥厚和左心室舒张功能减退发生率高;透析超滤量与MHD患者心脏舒张功能减退有一定的相关性,合理控制容量负荷对保护心脏功能有重要意义。 Objective To evaluate the changes of cardiac structure and function of maintenance hemodialysis (MHD) patients by color Doppler echocardiography and its risk factors for left ventricular diastolic dysfunction (LVDD). Methods The indicators of cardiac structure and function were tested in 100 patients who had been on dialysis for over 1 year and in stable status before MHD. Relevant clinical information and laboratory results were collected. Stepwise multiple regression analysis was used to analyze the factors influencing LVDD. Results The incidences of left ventricular hypertrophy (LVH) and LVDD were 82%, 69%, respectively. The patients were divided, based on early and late diastolic peak velocity ratio (E/A), into groups diastolic dysfunction ( E/A 〈 1, n = 69 ), normal diastolic function ( E/A ≥, n = 31 ). There was significant difference in age, ultrafiltration, ultrafiltration volume/body weight, BMI, right ventricular diameter, left ventricular end -diastolic diameter between 2 groups ( P 〈 0. 05 ). Multiple stepwise regression analysis showed that right ventricular diameter ultrafiltration/body weight was a factor influencing left ventricular diastolic function. Conclusion The incidences of LVH and LVDD are high in MHD patients. Ultrafiltration is related to LVDD. Rational control volume overload is of importance in protecting cardiac function.
出处 《中国全科医学》 CAS CSCD 北大核心 2014年第20期2329-2332,共4页 Chinese General Practice
基金 广东省科技厅立项资助课题(2012B031800209)
关键词 肾透析 左心室舒张功能减退 心脏结构 心脏功能 Renal dialysis Left ventrieular diastolic dysfunction Heart structure Heart function
  • 相关文献

参考文献14

  • 1McCullough PA, Li S, Jurkovitz CT, et al. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short -term mortality [J]. Am Heart J, 2008, 156 (2) : 277 -283.
  • 2Foley RN, Palfrey PS, Harnett JD, et al. Clinical and echocardio- graphic disease in patients starting end - stage renal disease therapy [J]. KidneyInt, 1995, 47 (1): 186-192.
  • 3London GM. Cardiovascular disease in chronic renal failure : pathophys- iologic aspects [J]. Semin Dial, 2003, 16 (2): 85-94.
  • 4王述平,李明旭,李洪艳.维持性血液透析对尿毒症患者左心室收缩和舒张功能的影响及其相关因素分析[J].临床内科杂志,2007,24(1):41-43. 被引量:3
  • 5Barberato SH, Bucharles SG, Sousa AM, et al. Prevalence and prog- nostic impact of diastolic dysfunction in patients with chronic kidney dis- ease on hemodialysis [J]. Arq Bras Cardiol, 2010, 94 (4) : 457 - 462.
  • 6Ahmed A, Rich MW, Sanders PW, et al. Chronic kidney disease as- sociated mortality in diastolic versus systolic heart failure: a propensity matched study [ J ]. The American Journal of Cardiology, 2007, 99 (3) : 393 - 398.
  • 7Floecari F, Granata A, Rivera Pt, et al. Echocardiography and right ventrieular function in NKF stage B eronic kidney disease: Ultrasound nephrologists' role [J]. Journal of Ultrasound, 2012, 15 (4) : 252 - 256.
  • 8桑晓红,马昆,彭钰.尿毒症患者心脏结构功能及相关危险因素分析[J].中国血液净化,2005,4(8):431-433. 被引量:15
  • 9蔡宏,严玉澄,陆任华,张敏芳,庞慧华,朱铭力,倪兆慧,钱家麒.维持性血液透析患者心脏结构功能的危险因素分析[J].临床肾脏病杂志,2011,11(7):308-311. 被引量:3
  • 10张英姿,刘宏,高民,刘必成.维持性血液透析患者贫血与左室舒张功能障碍的关系[J].中国医疗前沿,2009,4(17):18-18. 被引量:3

二级参考文献52

  • 1刘玉夏,朱丽芹,刘云启,成兆强,高金祥.左卡尼汀对血液透析患者心功能的作用[J].滨州医学院学报,2005,28(5):329-331. 被引量:10
  • 2Hugh C Rayner, Pisoni RL, Bommer J, et al. Mortality and hospi- talization in hemodialysis patients in five European Countries:Re- suits from the Dialysis outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant, 2004,19 .. 108-12(1.
  • 3Malik J, Tuka V, Mokrejsova M, et al. Mechanisms of chronic heart failure development in end-stage renal disease patients on chronic hemodialysis. Physiol Res,2009,58:613-621.
  • 4Naito Y,Tsujino T, Matsumoto M, et al. Daptive response of the heart to long-term anemia induced by iron deficiency. Am J Phys-iol Heart Cire Physiol, 2009,296 : H585-H593.
  • 5Ritz E. Left ventricular hypertrophy in renal disease: Beyond preload and afterload. Kidney Int, 2009,75 : 771-773.
  • 6Steigerwalt S, Zafar A, Mesiha N, et al. Role of aldosterone in left ventricular hypertrophy among African-American patients with end-stage renal disease on hemodialysis. Am J Nephrol,2007,27; 159-163.
  • 7Charra B, Chazot C. The neglect of sodium restriction in dialysis patients: A short review. Hemodial Int, 2003,7: 342-347.
  • 8Parfrey PS, Lauve M, Latremouille-Viau D, et al. Erythropoietin therapy and left ventricular mass index in CKD and ESRD pa- tients: A meta-analysis. Clin J Am Soc Nephrol, 2009,4: 755-762.
  • 9Hsu HJ,Wu MS. Fibroblast growth factor 23:A possible cause ofleft ventricular hypertrophy in hemodialysis patients. Am J Med- Sci,2009,337.. 116-122.
  • 10Eknoyan G, Beck GJ, Cheung A_K, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med, 2002,347 : 2010-2019.

共引文献37

同被引文献61

引证文献7

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部